Horizon Health Network

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Acute lymphoblastic leukaemia1 trial
• Chronic lymphocytic leukaemia1 trial
• Colorectal cancer1 trial
• Lung cancer1 trial
• Melanoma1 trial
• Multiple myeloma1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Canadian Cancer Trials Group3 trials
• CSL Behring1 trial

Running trials

• Recruiting

  Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  NCT07648264· Phase 3· CSL Behring· Source

  Contact: Trial Registration Coordinator

• Active, not recruiting

  Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

  NCT03057106· Phase 2· Canadian Cancer Trials Group· Source

• Recruiting

  Duration of Anti-PD-1 Therapy in Metastatic Melanoma

  NCT02821013· Phase 3· Canadian Cancer Trials Group· Source

  Contact: M. Saleem Raza

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Melanoma1 recruiting
• Multiple myeloma1 recruiting

Closed trials

• Completed

  Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

  NCT00819208· Canadian Cancer Trials Group· Source